**4. Conclusion**

In conclusion, the advent of using diagnostic kits with the ability to detect specific venom toxins and support of their access could potentially permit species implicated in snakebites to be deduced and ensure that treatments are targeted at toxins present in the victim's blood, as well as those that are known to be connected to the bites of particular species. Making available low-cost and heat-stable SMTs at the local level to high-risk areas could allow the administration of pre-hospital treatments after establishing envenomation that could lower the risks of tissue damage and paralysis. Subsequently, surveillance and treatment at a hospital may be procured using improved treatment approaches such as more specific monoclonal antibodies or AbScaffs [15, 56].
